Suppr超能文献

内皮细胞对2019冠状病毒病的影响。

Endothelial Cell Contributions to COVID-19.

作者信息

Oxford Alexandra E, Halla Fabio, Robertson Evan B, Morrison Brad E

机构信息

Department of Biological Sciences, Boise State University, Boise, ID 83725, USA.

Biomolecular Ph.D. Program, Boise State University, Boise, ID 83725, USA.

出版信息

Pathogens. 2020 Sep 25;9(10):785. doi: 10.3390/pathogens9100785.

Abstract

Understanding of the clinical, histological and molecular features of the novel coronavirus 2019 (Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)) has remained elusive. Coronavirus disease 2019 (COVID-19) caused by this virus has unusual clinical presentation with regard to other related coronaviruses. Recent reports suggest that SARS-CoV-2, unlike other related viruses, infects and replicates within endothelial cells, which may explain a significant portion of the observed clinical pathology. Likewise, mounting evidence associates vascular and endothelial cell dysfunction with increased mortality. This review focuses on understanding how endothelial cell pathology is caused by SARS-CoV-2 at the molecular and cellular levels and how these events relate to COVID-19. A detailed examination of current knowledge regarding canonical inflammatory reaction pathways as well as alteration of endothelial cell-derived exosomes and transdifferentiation by SARS-CoV-2 is included in this assessment. Additionally, given an understanding of endothelial contributions to COVID-19, potential therapeutic aims are discussed, particularly as would affect endothelial function and pathology.

摘要

对2019新型冠状病毒(严重急性呼吸综合征冠状病毒2,即SARS-CoV-2)的临床、组织学和分子特征的了解仍然有限。由这种病毒引起的2019冠状病毒病(COVID-19)在临床表现上与其他相关冠状病毒有所不同。最近的报告表明,与其他相关病毒不同,SARS-CoV-2在内皮细胞内感染并复制,这可能解释了观察到的临床病理学的很大一部分原因。同样,越来越多的证据表明血管和内皮细胞功能障碍与死亡率增加有关。本综述着重于了解SARS-CoV-2如何在分子和细胞水平上导致内皮细胞病变,以及这些事件与COVID-19的关系。本评估包括对当前关于经典炎症反应途径的知识以及SARS-CoV-2对内皮细胞衍生外泌体和转分化的改变的详细研究。此外,鉴于了解内皮细胞对COVID-19的影响,讨论了潜在的治疗目标,特别是那些会影响内皮功能和病理的目标。

相似文献

1
Endothelial Cell Contributions to COVID-19.内皮细胞对2019冠状病毒病的影响。
Pathogens. 2020 Sep 25;9(10):785. doi: 10.3390/pathogens9100785.
5
Drug Discovery Strategies for SARS-CoV-2.针对 SARS-CoV-2 的药物研发策略。
J Pharmacol Exp Ther. 2020 Oct;375(1):127-138. doi: 10.1124/jpet.120.000123. Epub 2020 Jul 28.
6
The Coronavirus Pandemic: What Does the Evidence Show?新冠疫情:证据表明了什么?
J Nepal Health Res Counc. 2020 Apr 19;18(1):1-9. doi: 10.33314/jnhrc.v18i1.2596.
7
Coronaviruses - a new old menace.冠状病毒——新的旧威胁。
Postepy Biochem. 2021 Jan 5;66(4):303-308. doi: 10.18388/pb.2020_357. Print 2020 Dec 31.
8
Coronavirus Disease 2019: Coronaviruses and Kidney Injury.2019 年冠状病毒病:冠状病毒与肾脏损伤。
J Urol. 2020 Nov;204(5):918-925. doi: 10.1097/JU.0000000000001289. Epub 2020 Jul 17.
10
Potential pathogenesis of severe acute respiratory syndrome coronavirus 2.严重急性呼吸综合征冠状病毒2的潜在发病机制。
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2020 May 28;45(5):591-597. doi: 10.11817/j.issn.1672-7347.2020.200299.

引用本文的文献

7
BPC 157 as Potential Treatment for COVID-19.BPC 157作为COVID-19的潜在治疗方法。
Med Hypotheses. 2021 Nov 9;158:110736. doi: 10.1016/j.mehy.2021.110736.

本文引用的文献

2
Dexamethasone in Hospitalized Patients with Covid-19.地塞米松在 COVID-19 住院患者中的应用。
N Engl J Med. 2021 Feb 25;384(8):693-704. doi: 10.1056/NEJMoa2021436. Epub 2020 Jul 17.
3
The role of extracellular vesicles in COVID-19 virus infection.细胞外囊泡在 COVID-19 病毒感染中的作用。
Infect Genet Evol. 2020 Nov;85:104422. doi: 10.1016/j.meegid.2020.104422. Epub 2020 Jun 13.
5
Immunology of COVID-19: Current State of the Science.COVID-19 的免疫学:科学现状。
Immunity. 2020 Jun 16;52(6):910-941. doi: 10.1016/j.immuni.2020.05.002. Epub 2020 May 6.
10
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验